Mara A. G. Hollander
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mara A. G. Hollander has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Julie M. Donohue
University of Pittsburgh Graduate School of Public Health, Department of Health Policy and Management, United States
5 shared publicationsElizabeth E. Krans
Department of Obstetrics, Gynecology & Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA, USA
3 shared publicationsAlisa B. Busch
Harvard Medical School, Boston, MA, USA
2 shared publicationsChung-Chou H. Chang
University of Pittsburgh School of Medicine, Division of General Internal Medicine, United States; University of Pittsburgh Graduate School of Public Health, Department of Biostatistics, United States
2 shared publicationsColleen L. Barry
Cornell Jeb E. Brooks School of Public Policy, Ithaca, NY, USA
2 shared publicationsElizabeth A. Stuart
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
2 shared publications
Latest Publications
- Open Access
- 3 January 2024
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 2 (1) , qxad089
Changes in institution for mental diseases (IMD) ownership status and insurance acceptance over time
State Medicaid programs are prohibited from using federal dollars to pay institutions for mental diseases (IMDs)—freestanding psychiatric facilities with more than 16 beds. Increasingly, regulatory mechanisms have made payment of treatment in these settings substantially more feasible. This study evaluates if changing financial incentives are associated with increases in for-profit ownership among IMD facilities relative to non-IMD facilities, as well as greater increases in Medicaid acceptance among for-profit IMD facilities relative to for-profit non-IMD facilities. We used data from the 2014–2020 National Mental Health Services Surveys and examined 11 945 facility-years. Relative to non-IMDs, the increase in for-profit ownership among IMDs was 6.6 percentage points greater. The largest proportional change in Medicaid acceptance occurred among for-profit IMD facilities relative to for-profit non-IMDs (18.5 percentage points). Existing research is mixed on the quality of inpatient and residential psychiatric care provided in for-profit vs nonprofit and public facilities, as well as in IMD relative to non-IMD facilities. As payment policy increasingly incentivizes for-profit facilities to enter the psychiatric care space, we should be mindful of the impact of these decisions on patient safety.
- 3 January 2024
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 2 (1) , qxad089
Open AccessChanges in institution for mental diseases (IMD) ownership status and insurance acceptance over time
State Medicaid programs are prohibited from using federal dollars to pay institutions for mental diseases (IMDs)—freestanding psychiatric facilities with more than 16 beds. Increasingly, regulatory mechanisms have made payment of treatment in these settings substantially more feasible. This study evaluates if changing financial incentives are associated with increases in for-profit ownership among IMD facilities relative to non-IMD facilities, as well as greater increases in Medicaid acceptance among for-profit IMD facilities relative to for-profit non-IMD facilities. We used data from the 2014–2020 National Mental Health Services Surveys and examined 11 945 facility-years. Relative to non-IMDs, the increase in for-profit ownership among IMDs was 6.6 percentage points greater. The largest proportional change in Medicaid acceptance occurred among for-profit IMD facilities relative to for-profit non-IMDs (18.5 percentage points). Existing research is mixed on the quality of inpatient and residential psychiatric care provided in for-profit vs nonprofit and public facilities, as well as in IMD relative to non-IMD facilities. As payment policy increasingly incentivizes for-profit facilities to enter the psychiatric care space, we should be mindful of the impact of these decisions on patient safety.
- 21 June 2023
- Published by SAGE Publications in Medical Care Research and Review
- Vol. 80 (5) , 530-539
Do High-Deductible Health Plans Incentivize Changing the Timing of Substance Use Disorder Treatment?
A high-deductible health plan (HDHP) may incentivize enrollees to limit health care use at the beginning of a plan year, when they are responsible for 100% of costs, or to increase the use of care at the end of the year, when enrollees may have less cost exposure. We investigated both the impact of the deductible reset that occurs at the beginning of a plan year and the option to enroll in an HDHP on the use of substance use disorder (SUD) treatment services over the course of a health plan year. We found decreases in SUD treatment use following the increase in cost exposure related to a deductible reset. There was no variation in this behavior between HDHP offer enrollees and comparison enrollees who were not offered an HDHP. These findings reinforce that cost-sharing poses a barrier to SUD care and continuity of care, which can increase the risk of adverse clinical outcomes.
- 21 June 2023
- Published by SAGE Publications in Medical Care Research and Review
- Vol. 80 (5) , 530-539
Do High-Deductible Health Plans Incentivize Changing the Timing of Substance Use Disorder Treatment?
A high-deductible health plan (HDHP) may incentivize enrollees to limit health care use at the beginning of a plan year, when they are responsible for 100% of costs, or to increase the use of care at the end of the year, when enrollees may have less cost exposure. We investigated both the impact of the deductible reset that occurs at the beginning of a plan year and the option to enroll in an HDHP on the use of substance use disorder (SUD) treatment services over the course of a health plan year. We found decreases in SUD treatment use following the increase in cost exposure related to a deductible reset. There was no variation in this behavior between HDHP offer enrollees and comparison enrollees who were not offered an HDHP. These findings reinforce that cost-sharing poses a barrier to SUD care and continuity of care, which can increase the risk of adverse clinical outcomes.
- Open Access
- 20 June 2023
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 1 (1) , qxad017
Patient-centered inpatient psychiatry is associated with outcomes, ownership, and national quality measures
Following discharge from inpatient psychiatry, patients experience elevated suicide risk, unplanned readmission, and lack of outpatient follow-up visits. These negative outcomes might relate to patient-centered care (PCC) experiences while hospitalized. We surveyed 739 former patients of inpatient psychiatric settings to understand the relationship between PCC and changes in patients’ trust, willingness to engage in care, and self-reported 30-day follow-up visits. We also linked PCC measures to facility-level quality measures in the Inpatient Psychiatric Facility Quality Reporting program. Relative to patients discharged from facilities in the top quartile of PCC, those discharged from facilities in the bottom quartile were more likely to experience reduced trust (predicted probability [PP] = 0.77 vs 0.46; P < .001), reduced willingness to go to the hospital voluntarily (PP = 0.99 vs 0.01; P < .001), and a lower likelihood of a 30-day follow-up (PP = 0.71 vs 0.92; P < .001). PCC was lower among patients discharged from for-profits, was positively associated with facility-level quality measures of 7- and 30-day follow-up and medication continuation, and was inversely associated with restraint use. Findings underscore the need to introduce systematic measurement and improvement of PCC in this setting.
- 20 June 2023
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 1 (1) , qxad017
Open AccessPatient-centered inpatient psychiatry is associated with outcomes, ownership, and national quality measures
Following discharge from inpatient psychiatry, patients experience elevated suicide risk, unplanned readmission, and lack of outpatient follow-up visits. These negative outcomes might relate to patient-centered care (PCC) experiences while hospitalized. We surveyed 739 former patients of inpatient psychiatric settings to understand the relationship between PCC and changes in patients’ trust, willingness to engage in care, and self-reported 30-day follow-up visits. We also linked PCC measures to facility-level quality measures in the Inpatient Psychiatric Facility Quality Reporting program. Relative to patients discharged from facilities in the top quartile of PCC, those discharged from facilities in the bottom quartile were more likely to experience reduced trust (predicted probability [PP] = 0.77 vs 0.46; P < .001), reduced willingness to go to the hospital voluntarily (PP = 0.99 vs 0.01; P < .001), and a lower likelihood of a 30-day follow-up (PP = 0.71 vs 0.92; P < .001). PCC was lower among patients discharged from for-profits, was positively associated with facility-level quality measures of 7- and 30-day follow-up and medication continuation, and was inversely associated with restraint use. Findings underscore the need to introduce systematic measurement and improvement of PCC in this setting.
- 13 May 2023
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 65 (5) , 800-808
Impact of High Deductible Health Plans on U.S. Adults With Chronic Pain
- 13 May 2023
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 65 (5) , 800-808
Impact of High Deductible Health Plans on U.S. Adults With Chronic Pain
- Open Access
- 1 January 2023
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 10
Complaints, Restraint, and Seclusion in Massachusetts Inpatient Psychiatric Facilities, 2008–2018
There has been limited research on the quality of inpatient psychiatry, yet policies to expand access have increased, such as the use of Medicaid Section 1115 waivers for treatment in “Institutions for Mental Disease” (IMD). Using data from public records requests, we evaluated complaints, restraint, and seclusion from inpatient psychiatric facilities in Massachusetts occurring from 2008 to 2018, and compared differences in the rates of these events by IMD status. There were 17,962 total complaints, with 48.9% related to safety and 19.9% related to abuse (sexual, physical, verbal), and 92,670 episodes of restraint and seclusion. On average, for every 30 census days in a given facility, restraint, and seclusion occurred 7.47 and 1.81 times, respectively, and a complaint was filed 0.94 times. IMDs had 47.8%, 68.3%, 276.9%, 284.8%, 183.6%, and 236.1% greater rates of restraint, seclusion, overall complaints, substantiated complaints, safety-related complaints, and abuse-related complaints, respectively, compared to non-IMDs. This is the first known study to describe complaints from United States inpatient psychiatric facilities. Policies should strengthen the implementation of patients’ rights and patient-centeredness, as well as external critical-incident-reporting systems.
- 1 January 2023
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 10
Open AccessComplaints, Restraint, and Seclusion in Massachusetts Inpatient Psychiatric Facilities, 2008–2018
There has been limited research on the quality of inpatient psychiatry, yet policies to expand access have increased, such as the use of Medicaid Section 1115 waivers for treatment in “Institutions for Mental Disease” (IMD). Using data from public records requests, we evaluated complaints, restraint, and seclusion from inpatient psychiatric facilities in Massachusetts occurring from 2008 to 2018, and compared differences in the rates of these events by IMD status. There were 17,962 total complaints, with 48.9% related to safety and 19.9% related to abuse (sexual, physical, verbal), and 92,670 episodes of restraint and seclusion. On average, for every 30 census days in a given facility, restraint, and seclusion occurred 7.47 and 1.81 times, respectively, and a complaint was filed 0.94 times. IMDs had 47.8%, 68.3%, 276.9%, 284.8%, 183.6%, and 236.1% greater rates of restraint, seclusion, overall complaints, substantiated complaints, safety-related complaints, and abuse-related complaints, respectively, compared to non-IMDs. This is the first known study to describe complaints from United States inpatient psychiatric facilities. Policies should strengthen the implementation of patients’ rights and patient-centeredness, as well as external critical-incident-reporting systems.
- 1 October 2021
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 227, 108927
Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use
- 1 October 2021
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 227, 108927
Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use
- 1 July 2021
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 78 (1) , 57-67
Emergency Department and Ambulatory Care Visits in the First Twelve Months of Coverage Under Medicaid Expansion: A Group-Based Trajectory Analysis
- 1 July 2021
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 78 (1) , 57-67
Emergency Department and Ambulatory Care Visits in the First Twelve Months of Coverage Under Medicaid Expansion: A Group-Based Trajectory Analysis
- 29 January 2021
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (8) , 2353-2360
Changes in Medicaid Utilization and Spending Associated with Homeless Adults’ Entry into Permanent Supportive Housing
Background There is growing interest in financing housing and supportive services for homeless individuals through Medicaid. Permanent Supportive Housing (PSH), which integrates non-time-limited housing with supportive services for people who are disabled and chronically homeless, has seen rapid growth in the last decade, but clear evidence on the long-term impacts of PSH, needed to guide state efforts to finance some PSH services through Medicaid, is lacking. Objective Assess changes in Medicaid expenditures and utilization associated with receiving PSH. Design Cohort study using a difference-in-differences approach. Participants A total of 1226 PA Medicaid enrollees who entered PSH 2011–2016 and remained in PSH for 180 days or more, and a matched comparison cohort of 970 enrollees experiencing housing instability who did not receive PSH. Main Measures Medicaid spending in aggregate, and on behavioral and physical health services; emergency department (ED) visits and inpatient hospital stays. Key Results Three years after PSH entry, spending decreased by an average of $145/month in the PSH cohort relative to changes in the comparison cohort (p = 0.046), with the greatest relative spending reductions occurring for residential behavioral health ($64, p < 0.001) and inpatient non-behavioral health services ($89, p = 0.001). We also found relative reductions in ED use (4.7 visits/100 person-months, p = 0.010) and inpatient hospital stays (1.6 visits/100 person-months, p < 0.001). Conclusions These results can inform emerging state efforts to finance PSH services through Medicaid. Additional state expenditures to expand financing for PSH services could be partially offset by reductions in Medicaid spending, in part by facilitating a shift in treatment to outpatient from acute care settings.
- 29 January 2021
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (8) , 2353-2360
Changes in Medicaid Utilization and Spending Associated with Homeless Adults’ Entry into Permanent Supportive Housing
Background There is growing interest in financing housing and supportive services for homeless individuals through Medicaid. Permanent Supportive Housing (PSH), which integrates non-time-limited housing with supportive services for people who are disabled and chronically homeless, has seen rapid growth in the last decade, but clear evidence on the long-term impacts of PSH, needed to guide state efforts to finance some PSH services through Medicaid, is lacking. Objective Assess changes in Medicaid expenditures and utilization associated with receiving PSH. Design Cohort study using a difference-in-differences approach. Participants A total of 1226 PA Medicaid enrollees who entered PSH 2011–2016 and remained in PSH for 180 days or more, and a matched comparison cohort of 970 enrollees experiencing housing instability who did not receive PSH. Main Measures Medicaid spending in aggregate, and on behavioral and physical health services; emergency department (ED) visits and inpatient hospital stays. Key Results Three years after PSH entry, spending decreased by an average of $145/month in the PSH cohort relative to changes in the comparison cohort (p = 0.046), with the greatest relative spending reductions occurring for residential behavioral health ($64, p < 0.001) and inpatient non-behavioral health services ($89, p = 0.001). We also found relative reductions in ED use (4.7 visits/100 person-months, p = 0.010) and inpatient hospital stays (1.6 visits/100 person-months, p < 0.001). Conclusions These results can inform emerging state efforts to finance PSH services through Medicaid. Additional state expenditures to expand financing for PSH services could be partially offset by reductions in Medicaid spending, in part by facilitating a shift in treatment to outpatient from acute care settings.
- 2 December 2019
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (8) , 2451-2458
Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty
The association between pharmaceutical industry promotion and physician opioid prescribing is poorly understood. Whether the influence of industry gifts on prescribing varies by specialty is unknown.
- 2 December 2019
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (8) , 2451-2458
Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty
The association between pharmaceutical industry promotion and physician opioid prescribing is poorly understood. Whether the influence of industry gifts on prescribing varies by specialty is unknown.
- 1 November 2019
- Published by Elsevier in Patient Education and Counseling
- Vol. 102 (11) , 2091-2096
A conceptual framework for understanding iatrophobia
- 1 November 2019
- Published by Elsevier in Patient Education and Counseling
- Vol. 102 (11) , 2091-2096
A conceptual framework for understanding iatrophobia